FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1162688000: Remogliflozin etabonate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4590934014 Remogliflozin etabonate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4590935010 Remogliflozin etabonate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Remogliflozin etabonate Is a Carbohydrate derivative true Inferred relationship Some
Remogliflozin etabonate Is a Sodium glucose cotransporter subtype 2 inhibitor true Inferred relationship Some
Remogliflozin etabonate This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing remogliflozin etabonate (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Remogliflozin etabonate Inferred relationship Some 1
Remogliflozin etabonate only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Remogliflozin etabonate Inferred relationship Some 1
Product containing only remogliflozin etabonate in oral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Remogliflozin etabonate Inferred relationship Some 1
Remogliflozin etabonate-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Remogliflozin etabonate Inferred relationship Some 1
Remogliflozin etabonate 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Remogliflozin etabonate Inferred relationship Some 1
Remogliflozin etabonate 100 mg oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. True Remogliflozin etabonate Inferred relationship Some 1

This concept is not in any reference sets

Back to Start